Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancerShun Lü, Yibin Wang, Jianya Zhou et al.|Translational Lung Cancer Research|2025Cited by 2